These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Arrhythmia triggers in heart failure: the smoking gun of [Ca2+]i dysregulation. Aistrup GL; Balke CW; Wasserstrom JA Heart Rhythm; 2011 Nov; 8(11):1804-8. PubMed ID: 21699870 [TBL] [Abstract][Full Text] [Related]
5. Spironolactone improves the arrhythmogenic substrate in heart failure by preventing ventricular electrical activation delays associated with myocardial interstitial fibrosis and inflammation. Esposito CT; Varahan S; Jeyaraj D; Lu Y; Stambler BS J Cardiovasc Electrophysiol; 2013 Jul; 24(7):806-12. PubMed ID: 23489714 [TBL] [Abstract][Full Text] [Related]
6. Arrhythmogenic Remodeling in the Failing Heart. Husti Z; Varró A; Baczkó I Cells; 2021 Nov; 10(11):. PubMed ID: 34831426 [TBL] [Abstract][Full Text] [Related]
7. When calcium turns arrhythmogenic: intracellular calcium handling during the development of hypertrophy and heart failure. Zaugg CE; Buser PT Croat Med J; 2001 Feb; 42(1):24-32. PubMed ID: 11172652 [TBL] [Abstract][Full Text] [Related]
9. Phytosterol accumulation results in ventricular arrhythmia, impaired cardiac function and death in mice. Ge H; Liu G; Yamawaki TM; Tao C; Alexander ST; Ly K; Fordstrom P; Shkumatov AA; Li CM; Rajamani S; Zhou M; Ason B Sci Rep; 2021 Aug; 11(1):17449. PubMed ID: 34465831 [TBL] [Abstract][Full Text] [Related]
10. Ion channels as novel therapeutic targets in heart failure. Akar FG; Tomaselli GF Ann Med; 2005; 37(1):44-54. PubMed ID: 15902846 [TBL] [Abstract][Full Text] [Related]
11. Quantitative systems models illuminate arrhythmia mechanisms in heart failure: Role of the Na Morotti S; Grandi E Wiley Interdiscip Rev Syst Biol Med; 2019 Mar; 11(2):e1434. PubMed ID: 30015404 [TBL] [Abstract][Full Text] [Related]
12. Right ventricular electrical remodeling and arrhythmogenic substrate in rat pulmonary hypertension. Tanaka Y; Takase B; Yao T; Ishihara M Am J Respir Cell Mol Biol; 2013 Sep; 49(3):426-36. PubMed ID: 23600532 [TBL] [Abstract][Full Text] [Related]
14. Neurohormonal Regulation of I Shugg T; Hudmon A; Overholser BR J Am Heart Assoc; 2020 Sep; 9(18):e016900. PubMed ID: 32865116 [TBL] [Abstract][Full Text] [Related]
15. Electrophysiologic considerations in congenital heart disease and their relationship to heart failure. Escudero C; Khairy P; Sanatani S Can J Cardiol; 2013 Jul; 29(7):821-9. PubMed ID: 23642334 [TBL] [Abstract][Full Text] [Related]
16. Mechanisms of disease: ion channel remodeling in the failing ventricle. Nass RD; Aiba T; Tomaselli GF; Akar FG Nat Clin Pract Cardiovasc Med; 2008 Apr; 5(4):196-207. PubMed ID: 18317475 [TBL] [Abstract][Full Text] [Related]
17. Analysis of electrolyte abnormalities and the mechanisms leading to arrhythmias in heart failure. A literature review. Urso C; Canino B; Brucculeri S; Firenze A; Caimi G Clin Ter; 2016; 167(4):e85-91. PubMed ID: 27598028 [TBL] [Abstract][Full Text] [Related]
18. Altered spatial calcium regulation enhances electrical heterogeneity in the failing canine left ventricle: implications for electrical instability. Iyer V; Heller V; Armoundas AA J Appl Physiol (1985); 2012 Mar; 112(6):944-55. PubMed ID: 22194323 [TBL] [Abstract][Full Text] [Related]
19. Signaling effectors underlying pathologic growth and remodeling of the heart. van Berlo JH; Maillet M; Molkentin JD J Clin Invest; 2013 Jan; 123(1):37-45. PubMed ID: 23281408 [TBL] [Abstract][Full Text] [Related]
20. Effect of levosimendan on ventricular arrhythmias and prognostic autonomic indexes in patients with decompensated advanced heart failure secondary to ischemic or dilated cardiomyopathy. Flevari P; Parissis JT; Leftheriotis D; Panou F; Kourea K; Kremastinos DT Am J Cardiol; 2006 Dec; 98(12):1641-5. PubMed ID: 17145226 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]